Assessing the Bleeding Severity in Type I Von Willebrand Patients Using the International Society on Thrombosis and Hemostasis Bleeding Assessment Tool ( ISTH-BAT) Questionnaire
Sponsor study identifier
observational
20
0 countries
N/A
Study Start
December 1, 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
December 1, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
March 1, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Applying the ISTH-BAT questionnaire on Egyptian patients with type I VWD aiming to correlate the BS with the laboratory findings
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 1, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 12, 2019
Actual (reported)April 16, 2019
Actual (reported)December 1, 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 1, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
March 1, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
the International Society on Thrombosis and Hemostasis-Bleeding Assessment Tool (ISTH-BAT)
Questionnaire minimum score ranges from 0 to 10 whereas maximum score ranges from 20 to 30
one year
blood sample
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
type 1 von willebrand egyptian patients
Contact the study team to confirm eligibility.
First Submitted
April 12, 2019
First Posted
April 16, 2019
Study Start
December 1, 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
December 1, 2020
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
March 1, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
September 10, 2019
Record last verified: 2019-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: